Phase 3 Randomized Low-Dose Paclitaxel Chemoradiotherapy Study for Locally Advanced Non-Small Cell Lung Cancer

INTRODUCTION: Concurrent chemoradiotherapy (CCRT) is the standard treatment for locally advanced non-small cell lung cancer (LA-NSCLC) but is associated with poor chest tumor control. Here, we report results of a randomized phase 3 study comparing two CCRT regimens in improving chest tumor control b...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hongmei, Chen, Yuhchyau, Shi, Anhui, Pandya, Kishan J., Yu, Rong, Yuan, Yannan, Li, Jiancheng, Li, Hang, Wang, Yingjie, Xia, Tingyi, Feng, Linchun, Ma, Huimin, Geng, Jianhao, Zhu, Guangying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168463/
https://www.ncbi.nlm.nih.gov/pubmed/28066716
http://dx.doi.org/10.3389/fonc.2016.00260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168463/
https://www.ncbi.nlm.nih.gov/pubmed/28066716
http://dx.doi.org/10.3389/fonc.2016.00260

Ejemplares similares